Brazil
· Delayed Price · Currency is BRL Raia Drogasil Statistics
Total Valuation
Raia Drogasil has a market cap or net worth of BRL 24.86 billion. The enterprise value is 32.12 billion.
| Market Cap | 24.86B |
| Enterprise Value | 32.12B |
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | Apr 30, 2025 |
Share Statistics
Raia Drogasil has 1.71 billion shares outstanding. The number of shares has decreased by -1.63% in one year.
| Current Share Class | 1.71B |
| Shares Outstanding | 1.71B |
| Shares Change (YoY) | -1.63% |
| Shares Change (QoQ) | +0.30% |
| Owned by Insiders (%) | 20.22% |
| Owned by Institutions (%) | 54.53% |
| Float | 856.18M |
Valuation Ratios
The trailing PE ratio is 20.42 and the forward PE ratio is 22.29. Raia Drogasil's PEG ratio is 1.33.
| PE Ratio | 20.42 |
| Forward PE | 22.29 |
| PS Ratio | 0.62 |
| PB Ratio | 3.82 |
| P/TBV Ratio | 5.56 |
| P/FCF Ratio | 19.13 |
| P/OCF Ratio | 9.38 |
| PEG Ratio | 1.33 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.99, with an EV/FCF ratio of 24.72.
| EV / Earnings | 27.36 |
| EV / Sales | 0.81 |
| EV / EBITDA | 7.99 |
| EV / EBIT | 13.72 |
| EV / FCF | 24.72 |
Financial Position
The company has a current ratio of 1.34, with a Debt / Equity ratio of 1.19.
| Current Ratio | 1.34 |
| Quick Ratio | 0.39 |
| Debt / Equity | 1.19 |
| Debt / EBITDA | 1.92 |
| Debt / FCF | 5.94 |
| Interest Coverage | 2.84 |
Financial Efficiency
Return on equity (ROE) is 18.68% and return on invested capital (ROIC) is 10.72%.
| Return on Equity (ROE) | 18.68% |
| Return on Assets (ROA) | 6.76% |
| Return on Invested Capital (ROIC) | 10.72% |
| Return on Capital Employed (ROCE) | 18.17% |
| Revenue Per Employee | 600,754 |
| Profits Per Employee | 17,712 |
| Employee Count | 64,758 |
| Asset Turnover | 1.84 |
| Inventory Turnover | 3.45 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.61% in the last 52 weeks. The beta is 0.17, so Raia Drogasil's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | -41.61% |
| 50-Day Moving Average | 17.92 |
| 200-Day Moving Average | 21.99 |
| Relative Strength Index (RSI) | 33.71 |
| Average Volume (20 Days) | 17,719,230 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Raia Drogasil had revenue of BRL 39.81 billion and earned 1.17 billion in profits. Earnings per share was 0.71.
| Revenue | 39.81B |
| Gross Profit | 11.77B |
| Operating Income | 2.34B |
| Pretax Income | 1.34B |
| Net Income | 1.17B |
| EBITDA | 3.06B |
| EBIT | 2.34B |
| Earnings Per Share (EPS) | 0.71 |
Balance Sheet
The company has 470.18 million in cash and 7.72 billion in debt, giving a net cash position of -7.25 billion or -4.23 per share.
| Cash & Cash Equivalents | 470.18M |
| Total Debt | 7.72B |
| Net Cash | -7.25B |
| Net Cash Per Share | -4.23 |
| Equity (Book Value) | 6.50B |
| Book Value Per Share | 3.79 |
| Working Capital | 3.36B |
Cash Flow
In the last 12 months, operating cash flow was 2.65 billion and capital expenditures -1.35 billion, giving a free cash flow of 1.30 billion.
| Operating Cash Flow | 2.65B |
| Capital Expenditures | -1.35B |
| Free Cash Flow | 1.30B |
| FCF Per Share | 0.76 |
Margins
Gross margin is 29.57%, with operating and profit margins of 5.88% and 2.95%.
| Gross Margin | 29.57% |
| Operating Margin | 5.88% |
| Pretax Margin | 3.36% |
| Profit Margin | 2.95% |
| EBITDA Margin | 7.70% |
| EBIT Margin | 5.88% |
| FCF Margin | 3.26% |
Dividends & Yields
This stock pays an annual dividend of 0.38, which amounts to a dividend yield of 2.59%.
| Dividend Per Share | 0.38 |
| Dividend Yield | 2.59% |
| Dividend Growth (YoY) | 23.26% |
| Years of Dividend Growth | 12 |
| Payout Ratio | 40.42% |
| Buyback Yield | 1.63% |
| Shareholder Yield | 4.21% |
| Earnings Yield | 4.72% |
| FCF Yield | 5.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 22, 2023. It was a forward split with a ratio of 1.04.
| Last Split Date | May 22, 2023 |
| Split Type | Forward |
| Split Ratio | 1.04 |
Scores
Raia Drogasil has an Altman Z-Score of 3.98.
| Altman Z-Score | 3.98 |
| Piotroski F-Score | n/a |